Literature DB >> 7683563

Porcine ventricular endocardial cells in culture express the inducible form of nitric oxide synthase.

J A Smith1, M W Radomski, R Schulz, S Moncada, M J Lewis.   

Abstract

1. We have investigated whether porcine endocardial cells in culture express the inducible, Ca(2+)-independent form of nitric oxide (NO) synthase. 2. NO synthase activity in cytosolic extracts of endocardial cells was measured by estimation of the rate of formation of L-[14C]-citrulline from L-[14C]-arginine. 3. Treatment of the cells in culture with lipopolysaccharide or cytokines induced a Ca(2+)-independent NO synthase activity in the cell cytosol. The combination of tumour necrosis factor (TNF alpha, 10 ng ml-1) and interleukin-1 beta (IL-1 beta, 10 ng ml-1) induced the greatest enzyme activity. 4. The increased Ca(2+)-independent NO synthase activity following exposure to cytokines was paralleled by an increase in guanosine 3':5'-cyclic monophosphate (cyclic GMP) levels in the endocardial cell cytosol. 5. Simultaneous addition of dexamethasone (0.01-1 microM) or cycloheximide (0.03-3 microM) inhibited in a concentration-dependent manner TNF alpha- and IL-1 beta-induced expression of Ca(2+)-independent NO synthase activity. Neither dexamethasone (1 microM) nor cycloheximide (3 microM) had any effect on the activity of the constitutive NO synthase. 6. The possible pathophysiological consequences of endocardial expression of the inducible NO synthase are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683563      PMCID: PMC1908162          DOI: 10.1111/j.1476-5381.1993.tb13512.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium.

Authors:  R Schulz; E Nava; S Moncada
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

Review 2.  St Cyres lecture. Endothelium in control.

Authors:  A H Henderson
Journal:  Br Heart J       Date:  1991-03

3.  Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells.

Authors:  R Busse; A Mülsch
Journal:  FEBS Lett       Date:  1990-11-26       Impact factor: 4.124

4.  Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 5.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

6.  Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin.

Authors:  R G Kilbourn; P Belloni
Journal:  J Natl Cancer Inst       Date:  1990-05-02       Impact factor: 13.506

7.  Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages.

Authors:  S S Gross; E A Jaffe; R Levi; R G Kilbourn
Journal:  Biochem Biophys Res Commun       Date:  1991-08-15       Impact factor: 3.575

8.  Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock.

Authors:  D D Rees; S Cellek; R M Palmer; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1990-12-14       Impact factor: 3.575

9.  Yohimbine increases submaxillary kallikrein release into the saliva in dogs: evidence for alpha 2-adrenoceptor-mediated inhibition of cholinergic pathways.

Authors:  J P Girolami; J L Bascands; C Pécher; M Berlan; J L Montastruc; P Montastruc
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

Review 10.  Does endocardium modulate myocardial contractile performance?

Authors:  M J Lewis; A M Shah; J A Smith; A H Henderson
Journal:  Cardioscience       Date:  1990-06
View more
  7 in total

Review 1.  The nitric oxide pathway in the cardiovascular system.

Authors:  S Llorens; J Jordán; E Nava
Journal:  J Physiol Biochem       Date:  2002-09       Impact factor: 4.158

2.  Label-free quantitative proteomics analysis reveals distinct molecular characteristics in endocardial endothelium.

Authors:  Abdul Jaleel; A Aneesh Kumar; G S Ajith Kumar; Arun Surendran; Chandrashekaran C Kartha
Journal:  Mol Cell Biochem       Date:  2018-06-22       Impact factor: 3.396

3.  The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha.

Authors:  R Schulz; D L Panas; R Catena; S Moncada; P M Olley; G D Lopaschuk
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

4.  Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease.

Authors:  A J de Belder; M W Radomski; H J Why; P J Richardson; J F Martin
Journal:  Br Heart J       Date:  1995-10

5.  Treatment with TNF-alpha or bacterial lipopolysaccharide attenuates endocardial endothelial cell-mediated stimulation of cardiac fibroblasts.

Authors:  Leena Kuruvilla; Cheranellore Chandrasekharan Kartha
Journal:  J Biomed Sci       Date:  2009-02-17       Impact factor: 8.410

Review 6.  Clinical review: Myocardial depression in sepsis and septic shock.

Authors:  Olivier Court; Aseem Kumar; Joseph E Parrillo; Anand Kumar
Journal:  Crit Care       Date:  2002-09-12       Impact factor: 9.097

7.  Proteomics Analysis Reveals Diverse Molecular Characteristics between Endocardial and Aortic-Valvular Endothelium.

Authors:  A Aneesh Kumar; G S Ajith Kumar; Gopika Satheesh; Arun Surendran; Mahesh Chandran; Chandrasekharan C Kartha; Abdul Jaleel
Journal:  Genes (Basel)       Date:  2021-06-30       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.